Experience

Kainjoo

• Switzerland
• Business Consulting and Services
• 1 - 100 Employee

• Partner Kainjoo Group SA

  • Sep 2021 - Present

  Marketing is no longer about merely adding online channels to the media mix; it is about integrating digital into all facets of marketing. Our global expertise and own network across digital analytics, market research, technology, business design, and online strategy can helps your company bring the full potential of digital marketing to launch new products and grow your business. We are disrupting Brands with emerging technologies for better consumer experiences. We are disrupting Healthcare for better patients outcomes.



Gnubiotics Sciences SA

• Lausanne, Switzerland

• Co Founder - CEO

  • Sep 2016 - Dec 2020

  Instrumental in the start-up of Gnubiotics Sciences, a biotech developing a platform to commercialize microbiome based modulating solutions for the nutrition and food markets. Develop and implement business plan for nutrition pipeline, set all new company & corporate processes and quality best practices, manage 3 founding rounds totalising CHF 9 million. Build founding team, manage operations with 6 FTEs and multiple CROs, establish global value chain with CMOs and structured co-development programs with early customers.



Nestlé Health Science

• Switzerland
• Pharmaceutical Manufacturing
• 700 & Above Employee

• Commercial Lead in Food Allergy business development for M&A

  • Jul 2015 - Jan 2016

  Responsible for global allergy development strategy definition with strong rationales in term of options, criteria and trade-offs, I managed opportunity sizing for acquisition opportunities in Allergy Diagnostic and Immuno Therapy. Leading multidisciplinary team for products/science assessment, in parallel with complementary market studies, I presented solid business cases to NHSc Executive team for investment decision. Outcomes was a multi-billion acquisition of a US biotech in Oct 2020. Responsible for global allergy development strategy definition with strong rationales in term of options, criteria and trade-offs, I managed opportunity sizing for acquisition opportunities in Allergy Diagnostic and Immuno Therapy. Leading multidisciplinary team for products/science assessment, in parallel with complementary market studies, I presented solid business cases to NHSc Executive team for investment decision. Outcomes was a multi-billion acquisition of a US biotech in Oct 2020.



Nestlé Nutrition SA

• Paris Area, France

• Directeur Commercial Nestlé Nutrition BabyNes

  • Apr 2012 - Jun 2015

  BabyNes, inspired by breastmilk, an evolving solution for infant nutrition up to 3 years with a series of 6 formulas to better match infant needs for optimum growth. After leading the process of setting business commercial operation in France, I took business leadership in France in January 2014 consolidating overall business unit and focused operations / investments on most effective drivers to deliver 46% growth despite PFME cuts. Achievements in 2014:  14% increase of active consumer base with new digital marketing campain  Kept excellent relationship with trade partner while focus presence in key urban clusters  Pilot new creative and innovative promotions to deliver 10% online sale increase  Smooth downsizing with 2 persons relocated  Organized unit with 2 key accounts, a marketing internship and shared resources.



Nestlé

• Switzerland
• Food and Beverage Services
• 700 & Above Employee

• International Trade Marketing Manager ANS

  • Jul 2009 - Mar 2012

  Conceptualised global RTM strategy for ground-breaking infant nutrition delivery system for Nestlé Executive board. Compiled lists of potential trade partners for retail and direct sales channels in 3 important markets. Projected sales volumes and marketing expenses. Drived an actionable Swiss market launch plan by June 2010 and ensured market deployment with trade load at the beginning of 2011.

• Business Development Manager - Pediatrics Specialities

  • Apr 2007 - Jun 2009

  Planned and executed global marketing strategy for premature and infant allergy formulas targeting markets in Europe and North America with business scope worth CHF 400 millions.



ARTeMED Management SA

• Geneva

• Co-founder and CEO

  • Dec 2003 - Dec 2006

  Engineered compelling business model that synthesised needs of all stakeholders including patients, surgeons, nurses and payers to establish cost-effective same-day surgery centres with modern operating theatres and best-in-class surgeons. Recruited and oversaw 60 staff members located across 3 sites. Captured CHF 16M in consolidated annual turnover within 3 years. Successful equity exit with an health insurance and management buyout returning x4 to early shareholders. Engineered compelling business model that synthesised needs of all stakeholders including patients, surgeons, nurses and payers to establish cost-effective same-day surgery centres with modern operating theatres and best-in-class surgeons. Recruited and oversaw 60 staff members located across 3 sites. Captured CHF 16M in consolidated annual turnover within 3 years. Successful equity exit with an health insurance and management buyout returning x4 to early shareholders.



CAPIO Healthcare - La Metairie SA

• Nyon

• CEO

  • Aug 1999 - Nov 2003

  Managing director of the newly acquired Swiss business by the CAPIO AB group, a leading European healthcare company. Business turn around (Annual turnover of CHF 18 millions / 140 employees) to establish double-digit net profit in a declining and more competitive market environment. Managing director of the newly acquired Swiss business by the CAPIO AB group, a leading European healthcare company. Business turn around (Annual turnover of CHF 18 millions / 140 employees) to establish double-digit net profit in a declining and more competitive market environment.